Overview

* Specialty insurance broker Ryan Specialty's ( RYAN ) Q3 revenue grows 24.8% yr/yr, beating analysts' expectations

* Company attributes revenue growth to organic growth and strategic investments

* However, Adjusted EPS for Q3 misses expectations

Outlook

* Company guides to double-digit organic revenue growth for full year 2025

* Company expects adjusted EBITDAC margin to be flat to modestly down for 2025

Result Drivers

* ORGANIC GROWTH - Co cites new client wins and expanded relationships as key drivers of 15% organic revenue growth

* ACQUISITIONS - Revenue growth supported by contributions from recent M&A transactions

* EXPENSE INCREASES - Higher compensation and benefits expenses due to increased headcount and revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $754.57 $741 mln

Revenue mln (10

Analysts

)

Q3 Miss $0.47 $0.48

Adjusted (14

EPS Analysts

)

Q3 $131.70

Adjusted mln

Net

Income

Q3 Net $62.60

Income mln

Q3 $110.79

Operatin mln

g Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the multiline insurance & brokers peer group is "buy"

* Wall Street's median 12-month price target for Ryan Specialty Holdings Inc ( RYAN ) is $70.00, about 27.3% above its October 29 closing price of $50.87

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)